Novo Nordisk increases transparency on tax payments

Due to a shift in Novo Nordisk's tax reporting policy, the firm will prospectively be more transparent about its global tax payments, states head of tax Camilla Wright.
Photo: Stine Tidsvilde
Photo: Stine Tidsvilde
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN

Danish pharmaceutical company Novo Nordisk is increasing its transparency on company tax payments, and in the future it will report on more detailed information from single markets in which the firm operates, according to Danish financial media Økonomisk Ugebrev.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading